西亚试剂：Nucleotide signalling during inflammation

发布时间：2025-11-04

Marco Idzko, Davide Ferrari & Holger K. Eltzschig

Inflammatory conditions are associated with the extracellular release of nucleotides, particularly ATP. In the extracellular compartment, ATP predominantly functions as a signalling molecule through the activation of purinergic P2 receptors. me-tabotropic P2Y receptors are G-protein-coupled, whereas ionotropic P2X receptors are ATP-gated ion channels. Here we discuss how signalling events through P2 receptors alter the outcomes of inflammatory or infectious diseases. Recent studies implicate a role for P2X/P2Y signalling in mounting appropriate inflammatory responses critical for host defence against invading pathogens or tumours. Conversely, P2X/P2Y signalling can promote chronic inflammation during ischaemia and reperfusion injury, inflammatory bowel disease or acute and chronic diseases of the lungs. Although nucleotide signalling has been used clinically in patients before, research indicates an expanding field of opportunities for specifically targeting individual P2 receptors for the treatment of inflammatory or infectious diseases.

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供

上一篇：西亚试剂：SIRT1，P53和p38MAPK调节Max缺失时ESC的死亡
下一篇：2019全球新能源企业500强榜单出炉